Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods

被引：10

作者：

Ross, JE ^{[1
]}

Jones, RN ^{[1
]}

机构：

[1] JMI Labs Inc, N Liberty, IA 52317 USA

来源：

关键词：

D O I：

10.1128/JCM.43.12.6212-6213.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：6212 / 6213

页数：2

共 9 条

[1] [Anonymous], 2003, NCCLS Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, V6th
[2] *CLIN LAB STAND I, 2005, DRUGS FUTURE, V25, P1163
[3] Pleuromutilin antibiotics
Hunt, E
[J]. DRUGS OF THE FUTURE, 2000, 25 (11) : 1163 - 1168
[4] Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: Initial development of in vitro susceptibility test methods
Jones, RN
Pfaller, MA
Rhomberg, PR
Walter, DH
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (02) : 461 - 465
[5] *NAT COMM CLIN LAB, 2003, M2A8 NCCLS
[6] *NAT COMM CLIN LAB, 2001, M23A2 NCCLS
[7] National Committee on Clinical Laboratory Standards, 2002, M31A2 NCCLS
[8] Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin
Pfaller, MA
Jones, RN
Walter, DH
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (1-2) : 67 - 70
[9] Walsh C., 2003, ANTIBIOTICS ACTIONS, P237